Navigation Links
PARI Respiratory Launches PEP S
Date:10/1/2009

MIDLOTHIAN, Va., Oct. 1 /PRNewswire/ -- Today, PARI Respiratory Equipment introduced the PEP S, a device that provides positive expiratory pressure that can be used with all PARI LC reusable nebulizers. PARI's PEP S can be used alone or in combination with nebulizer therapies for airway clearance and lung strengthening exercises by cystic fibrosis patients.

"I believe the new PARI PEP S is an incredible new device that improves patient care in two very important areas. It reduces treatment time by combining the PEP procedure with needed nebulized treatments. It may also enhance medication deposition with effective airway clearance during the nebulized treatment, especially in patients that find other modes of airway clearance cumbersome," said Dr. Sterling Simpson, pediatric pulmonologist, East Tennessee Children's Hospital.

"PARI is continually striving to improve respiratory therapies, and the PEP S is a time saver for cystic fibrosis patients. The PEP S allows for combination therapy with all of our LC reusable nebulizers, including the LC Sprint," said Geoff A. Hunziker, president of PARI Respiratory Equipment.

PARI's PEP S has eight adjustable resistance settings, covering a large expiratory flow range while achieving optimal resistance rates. Patients suffering from cystic fibrosis, lung diseases with secretory problems, and atelectasis (collapse of part or all of a lung) use PEP therapy to improve lung function by loosening thick, sticky mucus. PEP therapy has been shown to increase response to inhaled bronchodilators and is recommended by both the Cystic Fibrosis Foundation and the American Association for Respiratory Care.

About Cystic Fibrosis (CF)

Today, more than 30,000 people in the United States have CF. CF is a chronic, debilitating genetic disease. A major characteristic of CF is production of abnormally thick, sticky mucus in the lungs, trapping bacteria and predisposing patients to lung infections, which continually damage their lungs.

About PARI Respiratory Equipment, Inc.

PARI is a leading worldwide developer and manufacturer of fast and efficient aerosol delivery systems for patients with asthma, chronic lung disease, and cystic fibrosis. PARI's worldwide vision is to improve the lives of those affected by respiratory diseases and those who care for them.

Maker of the world's leading breath-enhanced reusable nebulizer, the PARI LC PLUS, and the new PARI LC Sprint nebulizer line, PARI also manufactures the award winning PARI TREK S compact compressor, Bubbles the Fish II aerosol mask, and durable PARI PRONEB Ultra II. Its Vortex Holding Chamber's anti-static, valved holding chamber improves the aerosol deposition of metered dose inhalers (MDIs). PARI's North American headquarters is in Midlothian, VA with worldwide headquarters in Starnberg, Germany. Online at www.Pari.com

SOURCE PARI Respiratory Equipment, Inc.


'/>"/>
SOURCE PARI Respiratory Equipment, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. QVA149 Phase II Data Presented at the European Respiratory Society Annual Meeting
2. Researchers Find Common Respiratory Virus Hijacks Lung Cells to Stay Alive
3. Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections
4. Novavax Announces Preclinical Data for Respiratory Syncytial Virus Vaccine Candidate
5. MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine
6. NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. CVS Caremark Launches Distribution of $3 million in Free Seasonal Flu Shot Vouchers to the Unemployed
9. Sagent Pharmaceuticals Launches Vinorelbine Injection, USP
10. Premier Heart Launches Multifunction CardioGram(TM) (MCG) In Latin America and the Caribbean
11. Paralyzed Artist Launches WillWalk Foundation to Cure Paralysis with Breakthrough Stem Cell Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... YORK , April 19, 2017 Global ... drainage devices are tubes used to remove excess liquid ... blood, serum, pus, urine, bile or lymph. Surgical drains ... of surgery such as orthopedics surgery, cardiovascular surgery, neurosurgery, ... is prophylactic post-surgery to prevent accumulation of fluid e.g. ...
(Date:4/19/2017)... , April 19, 2017 The ... Application, Forecast to 2022 report has covered and analysed the ... and information on market size, shares and growth factors. The ... drivers, challenges and opportunities in the global market. ... Browse 152 Tables and Figures, 6 ...
(Date:4/19/2017)... 2017  New research provides evidence that an old drug ... a study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... Parkinson,s disease, the oral drug levodopa has long been considered ... as the disease progresses, the effects of the medication can ...
Breaking Medicine Technology:
(Date:4/22/2017)... ... April 22, 2017 , ... ... PROSHRED® Security of Philadelphia its “Woman-Owned Small Business of the Year, ... providing information destruction , recycling, and compliance services to businesses throughout ...
(Date:4/21/2017)... ... 2017 , ... Providing broad access to life-saving drugs and rewarding the innovators ... way to address this problem. , That was the message from Dana Goldman, PhD, ... the University of Southern California, who served as the keynote speaker for Western University ...
(Date:4/21/2017)... Wis. (PRWEB) , ... April 21, 2017 , ... ... today announced that its B-595 and B-7569 vinyl label materials ... identification and warning labels are tested to remain intact and legible, for use on ...
(Date:4/21/2017)... Maine (PRWEB) , ... April 21, 2017 , ... ... today announced it’s been named Agency of Record (AOR) for Theravent, Inc. ... or eliminate snoring. Theravent’s parent company, Foundation Consumer Healthcare, is now working to ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... an exciting new partnership with the highly regarded and well renowned Asian distributor, ... innovative, myTAP & myTAP PAP Nasal Pillow Mask, and will stabilize and strengthen ...
Breaking Medicine News(10 mins):